PerspectiveDown Syndrome

Cognitive Enhancement Therapy for a Model of Down Syndrome

See allHide authors and affiliations

Science Translational Medicine  18 Nov 2009:
Vol. 1, Issue 7, pp. 7ps9
DOI: 10.1126/scitranslmed.3000449

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Down syndrome is a complex condition that results from having a third copy of human chromosome 21. People with the syndrome experience problems with learning and memory that affect many aspects of their lives. In this issue of Science Translational Medicine, Salehi et al. report on successful drug treatment of learning deficits in an animal model of Down syndrome. This study highlights the function of the norepinephrine-ergic system in Down syndrome and suggests possible treatment options for people with Down syndrome.


  • Citation: F. K. Wiseman, Cognitive enhancement therapy for a model of Down syndrome. Sci. Transl. Med. 1, 7ps9 (2009).

View Full Text

Stay Connected to Science Translational Medicine